Tag: on

My day on a plate: Vanda Serrador

Facialist and body-care expert at The Body Shop, Vanda Serrador, 42, shares her day on a plate. Vanda Serrador. 7.30am I start my day with a 15-minute meditation and an oil pulling (swishing around coconut oil in my mouth and then spitting it out), which helps to draw out toxins. 7.45am Cold-pressed juice with beetroot,

Top 5 reasons you should go on a social media detox

Nowadays, we have plenty of social networking sites to choose from, and the options seem to be ever expanding. Many people actually hold multiple accounts, which they may use for different purposes. I, for one, use one platform to communicate with friends and family, and another to stay up to date with the most recent

New study demonstrates toll of anxiety on bone health

Anxiety has already been shown to take its toll on the human body in many ways, including increased risk for heart disease and gastrointestinal disorders. Now a new study demonstrates how anxiety levels are linked to an increased risk of bone fractures in postmenopausal women. Study results are published online today in Menopause, the journal

Financial strain has major impact on patients’ health care decisions

Financial strain is the single most important factor in making health care decisions for low-income individuals, who often forgo care in favor of basic needs like food and rent, researchers in UT Southwestern’s Center for Patient-Centered Outcomes Research (PCOR) found. In addition, low-income individuals are often reluctant or too embarrassed to discuss their financial hardships

My day on a plate: Joel Creasy

Comedian, Joel Creasy, 27 shares his day on a plate. Joel Creasy 10am Throw out last night's pizza box en route to a cafe for a long black plus avocado, eggs and feta on toast, with a side of hash browns. 11.30am Head to the gym. I have another coffee while I train. 1pm Leave

Prescribing guidelines not always followed for patients on cholesterol-lowering drug

New Zealand prescribers do not always follow guidelines when prescribing other medicines to patients taking simvastatin, according to University of Otago researchers from the Pharmacoepidemiology Research Network. Simvastatin is a cholesterol-lowering drug that is widely used in New Zealand to prevent major cardiovascular events such as heart attacks and stroke. However, some medicines can inhibit

Bloomberg era’s emphasis on ‘health in all policies’ improved New Yorkers’ heart health

From 2002 to 2013, New York City implemented a series of policies prioritizing the public’s health in areas beyond traditional healthcare policies and illustrated the potential to reduce cardiovascular disease risk. This strategy is known as employing a “health in all policies” approach. Researchers at Columbia University’s Mailman School of Public Health catalogued health-relevant legislation

Toxin floats on lipid rafts

Helicobacter pylori, the leading cause of peptic ulcer disease and stomach cancer. One factor important to H. pylori infection is the pore-forming toxin VacA. It is thought to gain entry into host cells by binding to specialized membrane domains called lipid rafts. Using Giant Plasma Membrane Vesicles (GPMVs), Anne Kenworthy, Ph.D., and colleagues studied how

New guideline: Start taking MS drugs early on

For most people, it’s better to start taking drugs for multiple sclerosis (MS) early on rather than letting the disease run its course, according to a new guideline for treating MS from the American Academy of Neurology. The guideline is published in the April 23, 2018, online issue of Neurology, the medical journal of the

Researchers report on tumor transition states

Tumor heterogeneity describes the differences between different cells within a given tumor. These differences have major implications for the diagnosis, prognosis, and therapy of cancer patients. Different mechanisms have been proposed to account for tumor heterogeneity such as epithelial to mesenchymal transition (EMT), a process in which epithelial tumor cells loose their adhesion and acquire

Top HIV cure research team refutes major recent results on how to identify HIV persistence

An international team focused on HIV cure research spearheaded by The Wistar Institute in collaboration with the University of Pennsylvania and Vall d’Hebron Research Institute (VHIR) in Barcelona, Spain, established that the CD32 molecule is not a preferential biomarker to identify HIV silent reservoirs within the immune system of patients undergoing antiretroviral therapy (ART), as

FDA cracks down on caffeine-loaded supplements

(HealthDay)—The U.S. Food and Drug Administration announced Friday that it has issued tough new restrictions on the sale of dietary supplements that contain dangerously high amounts of caffeine. Supplements that contain pure or highly concentrated caffeine in powder or liquid forms are no longer permitted to be sold in bulk quantities directly to consumers, the